Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7262046 | 1.00 | CYP3A4 (0.48) | CYP3A4TSHRLMNAGAAALDH1A1 | |
| SCHEMBL15301352 | 0.94 | TSHR (0.50) | CYP3A4TSHRLMNAGAAALDH1A1 | |
| SCHEMBL15301131 | 0.92 | CYP3A4 (0.63) | CYP3A4TSHR | |
| SCHEMBL15300784 | 0.90 | CYP3A4 (0.39) | CYP3A4TSHRLMNAGAAMEN1 | |
| SCHEMBL25015131 | 0.88 | CYP3A4 (0.68) | CYP3A4TSHR | |
| SCHEMBL5963416 | 0.88 | CYP3A4 (0.68) | CYP3A4TSHR | |
| SCHEMBL25569013 | 0.86 | ACHE (0.41) | CYP3A4TSHRLMNAGAA | |
| SCHEMBL20017131 | 0.86 | ALDH1A1 (0.42) | CYP3A4TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL575208 | 0.83 | SMN1; SMN2 (0.38) | CYP3A4TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL15301316 | 0.83 | CYP3A4 (0.61) | CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113130993-A | Electrolyte and electrochemical device thereof | 深圳市研一新材料有限责任公司 | 2021-07-16 | — | — | CN | claimed |
| CN-111066188-B | Lithium ion secondary battery | 日本电气株式会社 | 2023-06-27 | — | — | CN | disclosed |
| CN-110326153-B | Secondary battery and method of using the same | 远景AESC能源元器件有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-110637388-B | Electrolyte for lithium ion secondary battery and lithium ion secondary battery using same | 日本电气株式会社 | 2023-03-24 | — | — | CN | disclosed |
| US-11611107-B2 | Lithium ion secondary battery | NEC CORPORATION (JP) | 2023-03-21 | — | — | US | disclosed |
| CN-110720156-B | Lithium ion secondary battery | 日本电气株式会社 | 2023-01-06 | — | — | CN | disclosed |
| CN-109690860-B | Lithium secondary battery | 日本电气株式会社 | 2022-11-22 | — | — | CN | disclosed |
| US-11489202-B2 | Electrolyte solution for lithium ion secondary battery and lithium ion secondary battery using same | NEC CORPORATION (JP) | 2022-11-01 | — | — | US | disclosed |
| CN-115275324-A | Secondary battery and method for using secondary battery | 远景AESC日本有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-108701812-B | Negative electrode for lithium secondary battery and lithium secondary battery | 日本电气株式会社 | 2022-09-23 | — | — | CN | disclosed |
| US-20140322615-A1 | LITHIUM ION SECONDARY BATTERY | NEC CORPORATION (JP) | 2014-10-30 | — | — | US | disclosed |
| EP-2779297-A1 | LITHIUM ION SECONDARY BATTERY | NEC Corporation (JP) | 2014-09-17 | — | — | EP | disclosed |
| EP-2650959-A1 | LITHIUM SECONDARY BATTERY | Nec Corporation (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-20130266847-A1 | LITHIUM SECONDARY BATTERY | NEC ENERGY DEVICES, LTD. (JP) | 2013-10-10 | — | — | US | disclosed |
| US-20130230779-A1 | GEL ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | NEC ENERGY DEVICES, LTD. (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20060172201-A1 | Non-aqueous electrolyte and lithium secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1357628-A1 | NONAQUEOUS ELECTROLYTIC LIQUIDS AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-10-29 | — | — | EP | disclosed |
| EP-0825664-B1 | Non-aqueous electrolytic solutions and non-aqueous electrolyte cells comprising the same | MITSUI CHEMICALS INC (JP) | 2003-10-08 | — | — | EP | disclosed |
| EP-0825664-A1 | Non-aqueous electrolytic solutions and non-aqueous electrolyte cells comprising the same | Mitsui Chemicals, Inc. (JP) | 1998-02-25 | — | — | EP | disclosed |
| US-5580684-A | PHOSPHORIC ACID ESTER SOLVENT FOR LITHIUM SALT ELECTROLYTE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11611107-B2 | Lithium ion secondary battery | SCO2, LPO, KCNN2 | CYP3A4 2159/4885TSHR 2857/4885LMNA 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.